Source: Journal of Immunology. Unidade: HU
Assunto: MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POWELL JR, Daniel J et al. Administration of a CD25-Directed Immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. Journal of Immunology, v. 179, n. 7, p. 4919-4928, 2007Tradução . . Acesso em: 02 out. 2024.APA
Powell Jr, D. J., Felipe-Silva, A., Merino, M. J., Ahmadzadeh, M., Allen, T., Levy, C., et al. (2007). Administration of a CD25-Directed Immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. Journal of Immunology, 179( 7), 4919-4928.NLM
Powell Jr DJ, Felipe-Silva A, Merino MJ, Ahmadzadeh M, Allen T, Levy C, White DE, Mavroukakis S, Kreitman RJ, Rosenberg SA, Pastan I. Administration of a CD25-Directed Immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. Journal of Immunology. 2007 ; 179( 7): 4919-4928.[citado 2024 out. 02 ]Vancouver
Powell Jr DJ, Felipe-Silva A, Merino MJ, Ahmadzadeh M, Allen T, Levy C, White DE, Mavroukakis S, Kreitman RJ, Rosenberg SA, Pastan I. Administration of a CD25-Directed Immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. Journal of Immunology. 2007 ; 179( 7): 4919-4928.[citado 2024 out. 02 ]